FDA Warning On Gerber Formula Claims Strikes Familiar Chord With FTC Complaint
This article was originally published in The Tan Sheet
Executive Summary
An FDA warning letter to Nestle Infant Nutrition says Gerber Good Start Gentle’s labeling and the product’s website omit or obscure required disclaimers, rendering qualified health claims as unauthorized, and mischaracterize the product’s formulation.
You may also be interested in...
Gerber-FTC Settlement Stipulates Clinical Trials For Infant Formula Claims
FTC filed its complaint in 2014 alleging Gerber, part of Nestlé Nutrition North America, deceptively advertised that feeding Good Start Gentle formula to infants with a family history of allergies prevents or reduces the risk that the infants will develop allergies.
Gerber Good Start Formula Claim, ‘FDA Qualified’ Badge Draw FTC Complaint
Gerber turned “FDA's narrow letter” allowing a qualified health claim for Good Start formula “into a prominent gold badge,” says an FTC attorney. Gerber argues its research “indisputably substantiates” Good Start Gentle Formula products “reduce the risk of the most common infant allergy.”
Mead Johnson Labeling On Enfamil Pouches Draws Warning
Mead Johnson Nutrition is discussing with FDA whether labeling for Enfamil infant formula marketed in a pouch sufficiently explains safe storage of the product.